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Background: Seroepidemiologic studies have indicated an association between chronic 
Chlamydia pneumoniae infection and coronary heart disease. The organism, which is a 
common respiratory pathogen, has been demonstrated in atherosderotic lesions of the 
aorta and coronary arteries. Abdominal aortic aneurysms are frequently associated with 
atherosclerosis, and inflammation may actually be an important factor in aneurysmal 
dilatation. Hence it could be assumed that C. pneumoniae may play a role in maintaining 
an inflammation and triggering the development ofaortic aneurysms. 
Methods and Results: Specimens from abdominal aortic aneurysm were examined for the 
presence of C. pneumoniae by immunohistochemical analysis, the polymerase chain 
reaction amplifying ompl gene, transmission electron microscopy, and culture methods 
with histologically atherosderosis-negative human aortic tissues used as a control group. 
Chlamydial lipopolysaccharide and C. pneumoniae specific antigens were found by immu- 
nohistochemistry in 12 and 8 of 12 aneurysm specimens, respectively, and C, pneumoniae 
DNA could be demonstrated in 6 of 6 aneurysm specimens studied. Furthermore electron 
microscopy revealed the presence of Chlamydia-like elementary bodies in three of four 
aneurysm specimens tested. None of the control samples gave positive reaction in the 
polymerase chain reaction, and C. pneumoniae ntigens were not detected in any of them. 
Conclusions: C. pneumoniae is frequently found in the vessel wall of abdominal aortic 
aneurysm. The potential etiopathogenetic role of C. pneumoniae in the development of
these aneurysms remains to be studied. (J Vasc Surg 1997;25:499-505.) 
Chlamydia pneumoniae,  recently discovered 
human pathogen, is a common cause of respiratory 
infections worldwide. 1,2 It has been estimated that 
most people have two or three C. pneumoniae infec- 
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tions during their lifetime.1 The prevalence of anti- 
bodies to C. pneumoniae increases with age and oc- 
curs in more than 50% of middle-aged adults in 
Finland. z It is also markedly higher in men than in 
women in older age groups, a difference that in- 
creases with age z and is higher in smokers than in 
nonsmokers? 4 It can be estimated that approxi- 
mately half of the elderly men in Finland have 
chronic C. pneumoniae infection. 5 Recent studies 
have shown elevated C. pneumoniae antibody titers 
and the presence of immune complexes in most pa- 
tients with myocardial infarction and coronary heart 
disease, suggesting chronic infection. 5-9 Further- 
more C. pneumoniae has been demonstrated in ap- 
proximately 50% o f  atherosclerotic lesions from au- 
topsy and atherectomy tissue specimens but not in 
normal-appearing areas by electron microscopy, im- 
munohistochemistry, and the poiymerase chain reac- 
tion (PCR), confirming the findings of  seroepide- 
miologic studies. 1°,13 Moreover, persistent infection 
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Table I. Summary of demographic data, detection of C. pneumoniae by immunohistochemistry with
monoclonal ntibodies specific to clamydial lipopolysaccharide and C. pneumoniae proteins, 
immunoglobulin G antibody titers in serum, in circulating immune complex and bound to tissues, 
tissue polymerase chain reaction, transmission electron microscopy findings, and isolation results of 
12 patients with abdominal ortic aneurysms 
Immunohistochemistry Immunoglobulin G antibody titer in 
Patient Age 
no. Sex (yr) Smoking LPS Protein Serum Serum IC Tissue IC PCR EM Isolation 
1 F 65 no +++ ++ 16 <2 2 + - - 
2 M 76 yes +++ + <8 <2 <1 + NT  - 
3 M 65 no + - 16 8 4 + + - 
4 M 67 yes + + + + 512 4 >4 + NT  NT  
5 M 52 no " + + + + 32 2 NT  + NT  NT  
6 F 71 no + + 32 2 NT  + NT  NT  
7 M 64 no + + + - NT  NT  NT  NT  + NT  
8 M 73 yes + + + + NT  NT  NT  NT  + NT  
9 M 68 yes + + + 32 2 NT  NT  NT  NT  
10 M 67 yes + + + + NT  NT  NT  NT  NT  NT  
11 M 62 yes + + + - NT  NT  NT  NT  NT  NT  
12 M 54 yes + + + - 128 8 NT  NT  NT  NT  
LPS, Lipopolysaccharide; IC, immune complex; PCR, polymerase chain reaction; EM, electron microscopy; NT, not  tested. 
*Reactivity graded - /+/+ +/+ + +. 
and multiplication of C. pneumoniae in endothelial 
cells has been demonstrated in vitro. 14 
Abdominal aortic aneurysms have been associ- 
ated with atherosclerosis in older patients and are 
traditionally described as "atherosclerotic. " S In 
most cases a conspicuous inflammatory infiltrate is 
found between the media and adventitia nthe aneu- 
rysmal  wa l l ,  16 and it has been suggested that destruc- 
tion and weakening of the aortic wall may occur as a 
result of the release of inflammatory mediators in 
response to the atherosclerotic processY Inflamma- 
tion may actually be an important factor in aneurys- 
mal dilatation, although the initial triggers are ob- 
scure. Aneurysms of the ascending aorta have been 
described as a typical consequence of Treponema 
pallidum infection. Once syphilis has almost disap- 
peared, these aneurysms have also became rare. By 
contrast, abdominal aortic aneurysms have become 
common in industrialized countries in recent 
t imes .18 ,19  
Because C. pneumoniae has been shown to be 
prcsent in atherosclerotic lesions and it is capable of 
multiplying in the cells of the vessel wall, one may 
surmise that it could be an agent maintaining an 
inflammation and triggering aortic aneurysm. We 
report here the frequent presence of C. pneumoniae 
in the walls of abdominal ortic aneurysms by immu- 
nohistochemistry, the PCR, and transmission elec- 
tron microscopy. Further studies are required to elu- 
cidate the etiopathogenetic role of C. pneumoniae in 
this disease. 
SUBJECTS AND METHODS 
Patients and control group. Samples from 12 
consecutive patients undergoing the repair of ab- 
dominal aortic aneurysms atOulu University Hospi- 
tal in spring 1994 were examined. The demographic 
data of the patients are presented in Table I. The 
serum samples for serology were obtained before the 
operation was performed. During surgery aspecimen 
from the anterior wall of the aneurysm sac was ob- 
tained for histologic examination and bacterial cul- 
ture. Sfices of the aneurysmal wall were immersed in 
liquid nitrogen for PCR and C. pneumoniae culture 
and in 10% buffered formalin for immunohistochem- 
istry. Segments of the specimens were also fixed in a 
glutaraldehyde-formaldehyde mixture for electron 
microscopy studies. Furthermore a piece of the aneu- 
rysmal tissue was also taken for microbiologic analy- 
sis by conventional erobic and anaerobic culture. 
Because it was not possible to obtain control 
samples from living donor tissue, we therefore col- 
lected "normal" abdominal ortas from fresh cadaw 
ers in the Department ofForensic Medicine (provid- 
ed by Dr. Terttu S~irkioja). We succeeded in 
obtaining three age-matched male samples from 
nonarteriosclerotic abdominal ortas of men Idled in 
accidents. All autopsies were performed within 12 
hours of death. To control the method and possible 
errors in autopsy material we obtained punch biopsy 
specimens from ascending aortas during coronary 
artery bypass grafting procedures, which were then 
run at the same time. The same protocol was used for 
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Hg. 1. !mmunostaining ofaneurysmal aortic wall with Chlamydialipopolysaccharide-specific 
monoclonal antibody showing strong positive reaction i  macrophages of atherosclerotic 
plaque (a) and in smooth muscle cells beneath plaque (b). No staining is seen in normal aorta 
(c). Bar 50 ~m. 
all experiments performed on both patient and con- 
trol aortic material. Six of the control samples were 
from men, and three were from women (mean age, 
63 years; range, 45 to 73 years). Specimens with 
histologic evidence of athcrosclerosis were elimi- 
nated from this series. There was not sufficient tissue 
to run every test for each patient. All data recorded 
from the patients are reported. In addition, normal 
skin and uterine wall samples erved as negative con- 
trol tissues. 
Immunohistochemistry. The immunohisto- 
chemical staining of the formalin-fixed, paraffin-em- 
bedded tissues were performed by the avidin/strep- 
avidin-biotin-peroxidase method ofHsu et al.20 with 
the Vectastain ABC kit (Vector laboratories, Burlin- 
game, Calif.) or the Histostain SP kit (Zymed, San 
Francisco, Calif.). Hcmatoxylin-eosin was used as the 
counterstain. A Chlamydia group-specific mouse 
monoclonal antibody against lipopolysaccharide an- 
tigen, a species-specific monoclonal antibody against 
C. pneumoniae prepared in our laboratory by Dr. 
Andrei Kutlin (SUNY, New York, N. Y.), and rabbit 
polyclonal anti- C. pneumoniae were used in the im- 
munostainings. Rabbit antibody against Francisella 
tularensis and normal serum were used as control 
antibodies for both patient and control samples. (2. 
pneumoniae-infected HeLa cells were used as posi- 
tive control samples, and normal skin and uterine 
wall samples were used as negative control tissues. 
PCIL The tissue samples were treated with pro- 
teinase K (Sigma, St. Louis, Mo.) and Nonidet 
P-40/Tween-20 (Sigma) at final concentrations of
100 ~g/ml  and 0.5%, respectively. After incubation 
at 55°C overnight DNA was purified with a 
QIAamp tissue kit (QIAGEN, Hilden, Germany) 
according to the manufacturer's instructions. The 
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1 2 3 4 5 
,-- 145 bp 
Fig. 2. Southern blotting of polymerase chain reaction 
products obtained with ompl-specific primers: Lane 1, 
Positive control (DNA extracted from C. pneumoniae 
strain ICajaani 6), lanes 2 and 3, two control aortas, and 
lanes 3 and 4, aneurysm tissues of two patients. 
ofig0nucleotide primers used, SC5 (5'TGCCTG- 
T(AG)GGGAA(TC)CC(AT)(GT)CTGA(AT)CCA3' 
and SCH4 (5'GTCGAAAAGA(AT)AGTC(TA)C- 
C(GA)TAGTA3'), modified from previously pub- 
lished primer sequences 21,22 to be C. pneumoniae- 
specific by Dr. S. Rasmussen (University of 
California, San Francisco), which amplify a 145 bp 
sequence at the 5' end of C. pneumonia¢ ompl gene, 
were purchased from the Institute of Biotechnology, 
Helsinki, Finland. The PCR amplification mixture 
contained 1 mmol/L deoxynucleoside triphos- 
phates, 2 mmol/L MgC12, 50 mmol/L KC1, 10 
mmol/L Tris-HC1 (pH 8.3), 1.0 U Taq polymerase 
(Hytest, Turku, Finland), 50 pmol of each primer, 
and 14 p~l of processed and diluted sample with total 
reaction volume of 25 ~1. AmpfiWax beads (Perkin- 
Elmer Cetus, Norwalk, Conn.) were used to facilitate 
the "hot start" PCIL 23 After 5 minutes of denatur- 
ation at 94°C the samples were subjected to 40 
consecutive cycles of denaturation (94 ° C5 30 see), 
annealing, and extension (60 ° C, 45 sec) with a Per- 
kin-Elmer Cetus GeneAmp 9600 thermocycler. The 
final extension time was 6 minutes at 72°C after 
cycling had been completed. The PCR products 
were separated by electrophoresis on 3% agarose gels 
containing ethidium bromide (0.2 ~g/ml). DNA 
was transferred onto a nylon membrane- (Immobilon 
N, Millipore, Bedford, Mass.). The blot was hybrid- 
ized with a specific digoxigenin-labeled probe 
(5' CCATAT(TA)CT(GA)CCATCAATTAA3') in 
5× standard saline solution citrate, 1.0% (wt/vol) 
blocking reagent for nucleic acid hybridization 
(Boehringer-Mannheim, Mannheim, Germany), 
0.1% N-layroylsarcosine, and 0.02% sodium dodecyl 
sulphate at 43 ° C. The hybridized probe was de- 
tected by alkaline phosphatase-labeled anti-digoxige- 
nin Fab fragments with 5-bromo-4-chloro-3-in- 
dolyl-phosphate/nitroblue tetrazolium (Bio-Rad, 
Hercules, Calif.) as substrate. 
Transmission electron microscopy. Specimens 
for electron microscopy were fixed in a glutaralde- 
hyde-formaldehyde mixture (1% glutaraldehyde, 4% 
formaldehyde, 0.1 mol/L phosphate buffer, pH 7.4) 
and postfixed with buffered 1% osmiumtetroxide. 
Thin sections were cut with Ultracut E microtome 
(Reichert-Jtmg) and poststained with uranyl acetate 
and lead citrate (Carlsberg system, LKB, Sweden). 
The electron micrographs were taken with a JEOL 
1200EX transmission electron microscope operating 
at 60 kV. 
C. pneumoniae isolation. For culturing tissue 
specimens were homogenized in chlamydia transport 
medium with a tissue homogenizer and inoculated 
into HL cell monolayers, a human cell fine, in a 
24-well flat-bottomed tissue culture plate. Cultures 
were stained by the fluorescent antibody technique 
with chlamydia genus-specific monoclonal antibody 
CF-2. 
Measurement of C. pneumoniae antibodies. 
Immunoglobulin class-specific antibodies were mea- 
sured by the microimmunofluorescence m thod 5 
with elementary bodies of C. pneumoniae, strain I~- 
jaani 6, C. trachomatis, L2, fluorescein-conjugated 
anti-human immunoglobulin G (Kallestad, Austin, 
Texas), immunoglobulin A (Sigma, St. Louis, Mo.), 
and immunoglobulin M (Dako A/S, Glostrup, Den- 
mark). Immune complexes were precipitated from 
the serum samples with 3.5% polyethyleneglycol as 
described earlier. 5 Antibodies to C. pneumoniaewere 
measured by microimmunofluorescence from im- 
mune complexes dissolved in phosphate-buffered sa- 
line solution, pH 7.4 (PBS). For measurement of
tissue-bound antibodies a small piece of frozen aneu- 
rysmal aortic wall (four samples) was cut into pieces, 
immersed in a small volume of phosphate-buffered 
saline solution, and vortexed for 20 minutes. After 
centrifugation was performed, the supernatant was 
used for the measurement of antibodies to C. pneu- 
moniae antigen possibly present in the tissue. 
RESULTS 
The demographic data of the patients undergo- 
ing surgery for abdominal aortic aneurysms and in- 
cluded in the study is shown in Table I. Ten of 12 
patients were men, the age range was 52 to 76 years, 
and 7 of the patients were smokers. 
On histologic evaluation the aneurysmal speci- 
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Fig. 3. Chlamydia-like particle in vessel wall of abdominal ortic aneurysm of two patients (a 
and b). OM, Outer membrane; CM, cytoplasmic membrane; PS, periplasmic space; CF, collagen 
fibers. Bar 0.2 ~m. 
mens showed severe atherosclerosis with variable 
inflammatory infiltrates consisting mainly of lympho- 
cytes and plasma cells. Immunohistochemical exam- 
ination demonstrated chlamydial lipopolysaccharide- 
antigen in large amounts in the macrophages of the 
atherosclerotic plaques and in smooth-muscle c lls 
beneath the plaques in all 12 aneurysm specimens 
(Table I, Fig. 1). Staining with a polyclonal rabbit C. 
pneumoniae antiserum gave a similar picture. The 
staining with monoclonal C. pneumoniae-specific an- 
tibody was much weaker than lipopolysaccharide- 
staining and was observed mainly in macrophages; 4 
of the 12 specimens were negative. No positive stain- 
ing wa s observed in control specimens obtained from 
ascending and abdominal aorta nor in the negative 
control tissues with any of the antibodies used (Fig. 
1, C). Staining with the antitularaemia or normal 
rabbit or goat serum in all the specimens was also 
negative in all the specimens. 
The PCR amplification of ompt gene produced 
the expected 145 bp band for all six aneurysms 
tested, indicating the presence of chlamydial DNA 
(Table I). Control arterial wall specimens were nega- 
tive for C. pneumoniae DNA. The specificity of PCR 
product was confirmed by Southern hybridization 
with specific probe (Fig. 2). 
Four aneurysm specimens were examined by 
transmission electron microscopy. Typical Chla- 
mydia-like organisms were detected in three of four 
lesions (Table I). Structures were pear-shaped and 
had a bilayer cell wall structure (the outer membrane 
and the cytoplasmic membrane) and a large periplas- 
mic space (Fig. 3). The size (average 0.3 I~m) of 
these organisms was similar to that of cell culture- 
grown organisms. 
Isolation of C. pneumoniae was attempted from 
three aneurysm specimens with negative results. C. 
pneumoniae ntibodies were present in seven of eight 
serum samples tested in titers 16 to 512 (Table I), 
and circulating C. pneumoniae-specific mmune 
complexes were detected in six of eight sera studied. 
None of the patients had C. tracbomatis antibodies 
present in their sera. Patient 2 had neither serum 
antibodies nor circulating immune complexes 
present. Aneurysmal tissues from the first four pa- 
tients (Table I) were also tested for the presence of 
tissue-bound antibodies, and in three of them bound 
antibodies could be demonstrated. Aerobic and an- 
aerobic bacterial cultures from the specimens were 
negative in every instance. 
DISCUSSION 
C. pneumoniae is an obligatory intracellular bac- 
terium that is able to multiply in monocytes, alveolar 
macrophages, 24 and vascular endothelial cells :in 
vitro. 14 Furthermore it can cause a persistent infec- 
tion in cultured endothelial cells. 14 In this study we 
demonstrated the presence of chlamydial compo- 
nents in macrophages located in abdominal aortic 
aneurysm lesions and in smooth muscle cells beneath 
the plaques. This finding is very similar to that earlier 
demonstrated in atherosclerotic lesions, 1°,12 except 
that in those cases only approximately half of the 
lesions obtained at autopsy or from atherectomy tis- 
sues were positive for C. pneumoniae when electron 
microscopy, immunohistology, and PCR were used, 
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and often only one of the methods gave a positive 
finding. In this series all the aneurysms were positive 
by immunohistology and all six specimens studied by 
PCR, suggesting high numbers of C. pneumoniae in 
the samples and possible active infection in the le- 
sion. Furthermore we were able to demonstrate p ar- 
shaped C. pneumoniae-like organisms 1° in three of 
four aneurysm tissues examined by transmission elec- 
tron microscopy. The inability to culture the organ- 
ism from the aneurysm tissue was not unexpected; C.
pneumoniae has also been found in previous tudies 
to be difficult o isolate. 1° 
We demonstrated C. pneumoniae in the aneu- 
rysms by immunostaining with a Chlamydia-genus- 
specific antibody reacting with the lipopolysaccha- 
ride common to all chlamydial species, suggesting 
that chlamydial lipopolysaccharide is present in high 
amounts in this infection. The primers used in the 
PCR products in this study did not amplify DNA of  
C. trachomatis (data not  shown). Furthermore we 
have used the same primers for detection of C. pneu- 
moniae from different mouse tissues in our animal 
studies very successfully without false-positive find- 
ings from uninfected animals. The reactivity of most 
specimens with a monoclonal antibody recognizing 
only C. pneumoniae confirms that our findings are 
specific to C. pneumoniae. In addition, none of the 
patients had antibodies to C. trachomatis present in 
their sera. The presence of antibodies to C. psittaci, 
which is rare in Finland, was not excluded. 
Despite the direct evidence on the presence of C. 
pneumoniae in all 12 patients with abdominal aortic 
aneurysms, one patient had no C. pneumoniae anti- 
bodies, and two had only low titers present in the 
sera. A similar finding was reported earlier; only 60% 
of the autopsy sera obtained from persons with ath- 
erosclerotic lesions positive for C. pneumoniae con- 
tained demonstrable antibodies to C. pneumoniae. 2~
One explanation for this result could be binding and 
sequestration of the antibodies to C. pneumoniae 
antigens present in the circulation as immune com- 
plexes or in the tissues of the arterial walls. We were 
able to show here that one patient with a low-anti- 
body titer did have C. pneumoniae ntibodies present 
in circulating immune complexes, and we were also 
able to dissociate C. pneumoniae antibodies from 
aneurysmal tissue in three of four patients, although 
blood contamination could not be excluded in the 
case of those with circulating antibodies. 
The pathogenesis of abdominal aortic aneurysms 
is largely unknown. Degradation of  clastin and colla- 
gens in the aortic wall has been shown to impair its 
compliance and thus may lead to aneurysmal dilata- 
tion. 26 Increased proteolysis has been shown to play 
an important role in this process. 27 Inflammation has 
been shown to mediate connective tissue proteolysis, 
as best characterized in pulmonary inflammation as- 
sociated with emphysema. 2s Although the initiator is 
not known, it is possible that the massive presence of 
C. pneumoniae in these lesions could provoke and 
feed this inflammation. Chronic chlamydial infec- 
tions, although usually scarring and occluding, 29 also 
contain an inflammatory component that may partic- 
ipate in the formation of aneurysms. Interferon 7, 
produced in intracellular infections, is thought o be 
a key factor in inducing persistent chlamydial infec- 
tions 29 and is present in chronic chlamydial lesions. 3° 
It is known to induce oxidative processes, to reduce 
synthesis of collagen, to lead to activation ofelastase, 
and to inhibit the proliferation of vascular smooth 
muscle 31 and endothelial cells. 32 A bacterial protease 
has been described for C. psittaci, a3 and our prelimi- 
nary studies suggest hat C. pneumoniae either pro- 
duces itself or induces the production of several pro- 
teases when growing in the cell cultures (K. 
Valkonen et al., unpublished ata). Smoking is one 
major risk factor for abdominal aortic aneurysm, and 
stopping smoldng has recently been found to im- 
prove the prognosis for the disease. 34 The mecha- 
nism by which smoking affects the aneurysmal wall is 
unknown, but several authors have associated smok- 
ing with chronic C. pneumoniae infections. 3,4 It is 
tempting to speculate that the promotion of a 
chronic C. pneumoniae infection in the lungs by 
smoking could also lead to infection of the aneurys- 
mal walls by the same agent. Chronic obstructive 
pulmonary disease recently associated with C. pneu- 
moniae infection 35,36 is a major risk factor for aneu- 
rysmsfi 7Because antibiotics that are effective against 
C. pneumoniae exist, intervention trials would be a 
logical next step to confirm the association between 
C. pneumoniae infection and abdominal aortic aneu- 
rysms. 
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